Clinical Trial Update: A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study) [Phase 2]

View source ↗

Summary

Phase 2 NOVEL study assessing the safety and activity of Nexagon for venous leg ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcers

Drugs mentioned

• NEXAGON

Snippet

Sponsor: OcuNexus Therapeutics, Inc. | Conditions: Venous Ulcer | Phase 2 | Status: COMPLETED